EUCTR2018-000767-91-GB
Active, not recruiting
Phase 1
INtravenous Iron to Treat Anaemia in CriTical Care Survivors (INTACT): a feasibility study - INtravenous Iron to Treat Anaemia in CriTical Care Survivors (INTACT)
niversity of Oxford / Clinical Trials and Research Governance0 sites130 target enrollmentJune 14, 2018
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- niversity of Oxford / Clinical Trials and Research Governance
- Enrollment
- 130
- Status
- Active, not recruiting
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •(1\) Adult ICU/HDU (Level 2 or 3\) for \=48 hours and now deemed fit for discharge by the attending physician
- •(2\) Last measured laboratory haemoglobin \=100 g/l
- •(3\) Able to provide written informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range 80
- •F.1\.3 Elderly (\>\=65 years) yes
- •F.1\.3\.1 Number of subjects for this age range 50
Exclusion Criteria
- •(1\) Planned palliative care
- •(2\) Planned home ventilation
- •(3\) Primary neurological diagnosis
- •(4\) Requirement for English translation
- •(5\) Known hypersensitivity to iron
- •(6\) Immunosuppressive therapy for organ transplant
- •(7\) Intravenous iron or erythropoietin in the previous 4 weeks
- •(8\) Weight \= 50 kg
- •(9\) Already enrolled into another trial where the trial protocol explicitly prohibits co\-enrolment
- •(10\) Pregnancy (however, breastfeeding is not an exclusion criteria)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Treatment of anemia (low red blood cells) with iron infusions in patients listed for a liver transplantatioEUCTR2017-000703-24-ATMedical University of Vienna; Department of Surgery; Division of Transplantation60
Completed
Phase 3
Will Intravenous Inron reduce blood transfusion in patients undergoing treatment for ovarian cancerHealth Condition 1: C569- Malignant neoplasm of unspecifiedovaryCTRI/2019/05/019378Amrita University69
Active, not recruiting
Phase 1
Intravenous iron for treatment of anaemia before cardiac surgeryAnaemiaMedDRA version: 20.0Level: PTClassification code 10022972Term: Iron deficiency anaemiaSystem Organ Class: 10005329 - Blood and lymphatic system disordersTherapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]EUCTR2016-004439-19-GBAlfred Health1,000
Active, not recruiting
Phase 1
Intravenous iron supplement for patients with severe aortic stenosis who have iron deficiencyIron deficiency, aortic stenosisMedDRA version: 20.0 Level: HLT Classification code 10022971 Term: Iron deficiencies System Organ Class: 100000004861Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]EUCTR2019-002037-11-NOOslo University Hospital100
Recruiting
Not Applicable
INTRAVENOUS IRON TO TREAT POSTOPERATIVE ANEMIA IN OLDER CARDIAC SURGERY PATIENTS: A RANDOMIZED CONTROLLED TRIANL-OMON56336Sint Antonius Ziekenhuis310